France Bioproduction Congress 2022
Presentation | April 7th at 5:30 pm
How AI, ML and Continuous Manufacturing Technologies Can Drive Flexible cGMP Manufacturing of Kilograms to Metric Tons of Biologics Therapeutics: The J.POD® Facility Example
- Christelle Dagoneau, SVP Business Development, will give a presentation featuring artificial intelligence and machine learning capabilities at the J.POD
Christelle DagoneauSVP Business Development
Christelle has over 20 years of international business development and marketing experience in the life sciences and biologics CDMO industry. In her current role as SVP Business Development, Christelle leads the global Business Development team, with a focus on shaping innovative business strategies, building a strong industry presence and establishing Just – Evotec Biologics as a global leader in the AI-driven discovery to continuous manufacturing space. Prior to joining Just – Evotec Biologics, Christelle held several senior Business Development roles at Catalent where she supported the growth of the biologics division in Europe and led the European Cell Therapy Business Development team. Christelle also served as Head of Marketing and Sales at PX’Therapeutics, a French biologics CDMO and brings in an expert knowledge of the biotherapeutics and biosimilars markets, a passion for building strategic partnerships as well as strong Business Development culture and best practices.
Christelle received her Ph.D. in Organic Chemistry from the University of Grenoble, France and also holds a master in Technology & Business Management.